Register Login

ELUTIA INC. (ELUT)

(19% Negative) ELUTIA INC. (ELUT) Announces Delay in infection Trials for drug-eluting biomatrix technologies Due to Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Aug. 21, 2026, 9:01 p.m.

    📋 ELUTIA INC. (ELUT) - Clinical Trial Update

    Filing Date: 2026-08-21

    Accepted: 2026-08-21 17:00:20

    Event Type: Clinical Trial Update

    Event Details:

    ELUTIA INC. (ELUT) Announces Clinical Trial Update ELUTIA INC. (ELUT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: infection, expected
    • Diseases/Conditions: drug-eluting biomatrix technologies
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: GLOBE NEWSWIRE
      • expected in the first half of 2027

    🔬 Clinical Development Pipeline (ELUTIA INC.):

    Product Type Development Stage Therapeutic Area Source
    EluPro Antibiotic-Eluting BioEnvelope Other Preclinical Cardiac Arrhythmias ClinicalTrials.gov
    Bone Morphogenetic Protein Other Preclinical Spondylolisthesis ClinicalTrials.gov
    Demineralized Bone Matrix Other Preclinical Spondylolisthesis ClinicalTrials.gov
    ViBone® Other Preclinical Spondylolisthesis ClinicalTrials.gov
    CorMatrix CanGaroo ECM Envelope Other Preclinical Coronary Disease ClinicalTrials.gov
    TYRX Envelope Other Preclinical Cardiac Disease ClinicalTrials.gov
    CanGaroo Envelope Other Preclinical Cardiac Disease ClinicalTrials.gov
    CorMatrix ECM for Vascular Repair Other Preclinical Peripheral Vascular Disease ClinicalTrials.gov
    CorMatrix ECM for Carotid Repair Other Preclinical Carotid Stenosis ClinicalTrials.gov
    CorMatrix ECM for Pericardial Closure Other Approved Atrial Fibrillation New Onset ClinicalTrials.gov
    CIED envelope Other Preclinical Cardiac Disease ClinicalTrials.gov
    DermACELL HADM Other Preclinical Breast Cancer ClinicalTrials.gov
    FlexHD HADM Other Preclinical Breast Cancer ClinicalTrials.gov
    AlloMax HADM Other Preclinical Breast Cancer ClinicalTrials.gov
    AlloDerm HADM Other Preclinical Breast Cancer ClinicalTrials.gov
    SimpliDerm HADM Other Preclinical Breast Cancer ClinicalTrials.gov
    ViBone Other Preclinical Spondylosis ClinicalTrials.gov
    CanGaroo Other Approved Heart Diseases ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ELUTIA INC.
    • Ticker Symbol: ELUT

Search

News categories